Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors.
Hyo Jin KimDong Hyun SinnNam Jun KimJung Hee KimEun KimGeum-Youn GwakYong-Han PaikMoon Seok ChoiJoon Hyeok LeeKwang Cheol KohSeung Woon PaikByung Chul YooPublished in: Digestive diseases and sciences (2015)
The baseline HBV DNA level was indicator for sustained off-treatment virological response after stopping preemptive antiviral therapy. Consolidation treatment duration showed association with sustained off-treatment virological response only for those with low baseline HBV DNA levels.